Monograph Details
|
|
Eye Disorders
> Ocular allergy/inflammation
|
|
MAXIDEX |
| Manufacturer |
|
Alcon Laboratories, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Steroid. |
| Generic Name |
|
Dexamethasone 0.1%; oph susp; contains benzalkonium chloride. |
| Indications |
|
Ocular inflammation. |
| Children |
|
Not recommended. |
| Adults |
|
Initially 1–2 drops hourly, then prolong dosing interval to 4–6 times daily as condition improves. |
| Contraindications |
|
Fungal, mycobacterial, or viral (except herpes zoster) infections of the eye. |
| Precautions |
|
Corneal or scleral thinning. Glaucoma. Monitor for secondary infections and intraocular pressure in prolonged use. Avoid abrupt cessation. Pregnancy (Cat.C). Nursing mothers. |
| Adverse Reactions |
|
Local irritation, increased intraocular pressure, cataracts, corneal perforations, optic nerve damage; may mask or exacerbate infections, delay wound healing. |
| How Supplied |
|
Susp—5mL, 15mL |
|
|
|
|
